Back

dr. G.W.J. (Geert) Frederix

dr. G.W.J. (Geert) Frederix

Associate Professor

Show full profile

Research Output (73)

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective

Bokkers K, Frederix G W J, Velthuizen M E, van der Aa M, Gerestein C G, van Dorst E B L, Lange J G, Louwers J A, Koole W, Zweemer R P, Ausems M G E M 25 Aug 2022, In: Gynecologic Oncology. 167 , p. 115-122 8 p.

Cost-effectiveness of the implementation of [Ga-68]Ga-PSMA-11 PET/CT at initial prostate cancer staging

van der Sar Esmee C. A., Keusters Willem R., van Kalmthout Ludwike W. M., Braat Arthur J. A. T., de Keizer Bart, Frederix Geert W. J., Kooistra Anko, Lavalaye Jules, Lam Marnix G. E. H., van Melick Harm H. E. 13 Aug 2022, In: Insights into Imaging. 13 , p. 1-10

Medical costs of children admitted to the neonatal intensive care unit:The role and possible economic impact of WES in early diagnosis

Olde Keizer Richelle A.C.M., Marouane Abderrahim, Deden A. Chantal, van Zelst-Stams Wendy A.G., de Boode Willem P., Keusters Willem R., Henneman Lidewij, van Amstel Johannes Kristian Ploos, Frederix Gerardus W.J., Vissers Lisenka E.L.M. May 2022, In: European Journal of Medical Genetics. 65

The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer

de Rouw Nikki, de Boer Merel, Boosman René J., van den Heuvel Michel M., Burger David M., Lieverse Joris E., Derijks Hieronymus J., Frederix Geert W.J., ter Heine Rob May 2022, In: Clinical Pharmacology and Therapeutics. 111 , p. 1103-1110 8 p.

Cost-effectiveness analysis of 1.5T MRI-guided radiotherapy: A survey in the MR-Linac Consortium

Hehakaya C., van Zijp J. R. van der Voort, Grobbee D. E., Verkooijen H. M., Frederix G. F. May 2022, In: Radiotherapy and Oncology. 170 , p. S885-S886

Market access to new anticancer medicines for children and adolescents with cancer in Europe

Schoot Reineke A., Otth Maria A., Frederix Gerardus W.J., Leufkens Hubert G.M., Vassal Gilles Apr 2022, In: European Journal of Cancer. 165 , p. 146-153 8 p.

Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir:ein Scoping-Review

van Lieshout Chris, Schuit Ewoud, Hermes Carsten, Kerrigan Matthew, Frederix Geert W J 11 Mar 2022, In: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 169 , p. 28-38 11 p.

Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England

ten Ham Renske M.T., Frederix Geert W.J., Wu Olivia, Goettsch Wim, Leufkens Hubert G.M., Klungel Olaf H., Hoekman Jarno Mar 2022, In: Value in Health. 25 , p. 390-399 10 p.

Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A

Ten Ham Renske M T, Walker Sikon M, Soares Marta O, Frederix Geert W J, Leebeek Frank W G, Fischer Kathelijn, Coppens Michiel, Palmer Stephen J 28 Feb 2022, In: HemaSphere. 6 , p. 1-11

Cost-Effectiveness of a Multidisciplinary Lifestyle-Enhancing Treatment for Inpatients with Severe Mental Illness:The MULTI Study v

Deenik Jeroen, Van Lieshout Chris, Van Driel Harold F., Frederix Geert W.J., Hendriksen Ingrid J.M., Van Harten Peter N., Tenback Diederik E. 1 Jan 2022, In: Schizophrenia Bulletin Open. 3

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not